VOYA Investment Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.8M Buy
49,461
+1,408
+3% +$44.4K ﹤0.01% 1285
2026
Q1
$1.35M Sell
48,053
-129
-0.3% -$4.23K ﹤0.01% 1357
2025
Q4
$1.8M Sell
48,182
-4,031
-8% -$133K ﹤0.01% 1252
2025
Q3
$1.44M Buy
52,213
+18,812
+56% +$648K ﹤0.01% 1357
2025
Q2
$1.06M Buy
33,401
+6,679
+25% +$215K ﹤0.01% 1557
2025
Q1
$887K Buy
26,722
+3,851
+17% +$138K ﹤0.01% 1623
2024
Q4
$787K Buy
22,871
+144
+0.6% +$4.95K ﹤0.01% 1721
2024
Q3
$909K Sell
22,727
-3,129
-12% -$110K ﹤0.01% 1701
2024
Q2
$780K Sell
25,856
-543
-2% -$16.3K ﹤0.01% 1760
2024
Q1
$886K Buy
26,399
+1,266
+5% +$40.6K ﹤0.01% 1693
2023
Q4
$812K Buy
25,133
+4,254
+20% +$119K ﹤0.01% 1796
2023
Q3
$684K Buy
20,879
+188
+0.9% +$6.53K ﹤0.01% 1870
2023
Q2
$728K Buy
20,691
+2,889
+16% +$99.7K ﹤0.01% 1867
2023
Q1
$581K Sell
17,802
-118
-0.7% -$5.37K ﹤0.01% 1965
2022
Q4
$987K Hold
17,920
– – ﹤0.01% 1650
2022
Q3
$794K Buy
17,920
+2,910
+19% +$142K ﹤0.01% 1753
2022
Q2
$732K Buy
15,010
+5,791
+63% +$261K ﹤0.01% 1603
2022
Q1
$449K Buy
9,219
+401
+5% +$16.4K ﹤0.01% 1981
2021
Q4
$376K Sell
8,818
-43
-0.5% -$1.71K ﹤0.01% 2180
2021
Q3
$340K Hold
8,861
– – ﹤0.01% 2274
2021
Q2
$250K Buy
+8,861
New +$266K ﹤0.01% 2471

Other funds holding HRMY

VOYA Investment Management's HRMY Position: Q2 2026 in Review

VOYA Investment Management increased its Harmony Biosciences (HRMY) stake by 2.9% in Q2 2026, buying an estimated $44.4K and bringing the position to 49,461 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

VOYA Investment Management first reported a position in HRMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.8M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • VOYA Investment Management held 49,461 shares of Harmony Biosciences worth $1.8M as of Q2 2026.
  • VOYA Investment Management bought 1,408 Harmony Biosciences shares in Q2 2026, an estimated $44.4K.
  • Harmony Biosciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1285 holding.
  • VOYA Investment Management first reported a position in Harmony Biosciences in Q2 2021 and has held it in 21 quarters since.
  • VOYA Investment Management's Harmony Biosciences position peaked at $1.8M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.